COPILOT Grows its Senior Leadership Talent
Seasoned healthcare executive Michael DeVries Joins COPILOT
Michael brings over 20 years of experience in healthcare technology, finance, and strategic leadership, with a proven track record of driving financial performance and growth in the healthcare industry. He joins COPILOT from Blue Lantern Health, where he served as CFO. Prior to his tenure at Blue Lantern Health, Michael was Vice President of Finance at Greenway Health where he led the finance team through acquisitions, system implementations, and strategic and operational effectiveness initiatives. Early in his career, Michael held significant roles at Allscripts, Nortel Networks, and State Street Bank.
"We are excited to welcome Michael to COPILOT"
"I am excited to join COPILOT and contribute to its vision of improving patient access," said
Michael earned his MBA from The University of North Carolina, Kenan-Flagler Business School, and a Bachelor of Arts in Economics from The University of Western Ontario. His extensive experience and leadership will be a significant asset to COPILOT as the company continues to innovate and lead the way in the patient access space.
About COPILOT Provider Support Services
COPILOT technology enables highly accurate and timely benefits investigation to provider staff and practice management navigating the challenges of reimbursement for complex, high-cost specialty products. Our real-time, easily accessible, web-based portal securely displays accurate data that brings value to provider offices and Pharma clients to best manage each patient's journey. With an experienced team and longevity in HUB and reimbursement services, we provide guidance in market access and drive high satisfaction for our clients.
For more information, please visit www.cmcopilot.com.
Media Contact
[email protected]
347-287-5355
View original content to download multimedia:https://www.prnewswire.com/news-releases/copilot-grows-its-senior-leadership-talent-302181590.html
SOURCE COPILOT Provider Support Services
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aker BP: Second quarter 2026 results
- In 2025, NRD Cyber Security saw growth in both its project-based activities and ongoing services
- FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share